Massimo A. Siciliano
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.
Journal: Alimentary pharmacology & therapeutics
Published: May 18, 2023
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography.
Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)
Published: December 16, 2022
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.
Journal: ESMO open
Published: November 19, 2021
"Say Ninetynine": It's Never too Late to Recover from COVID-19.
Journal: The Journal of frailty & aging
Published: December 17, 2020
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project.
Journal: Journal of viral hepatitis
Published: June 21, 2020
Contrast-Enhanced Ultrasound in the Short-Term Evaluation of Hepatocellular Carcinoma after Locoregional Treatment.
Journal: Digestive diseases (Basel, Switzerland)
Published: November 03, 2019
Regorafenib: a promising treatment for hepatocellular carcinoma.
Journal: Expert opinion on pharmacotherapy
Published: October 23, 2018
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?
Journal: European journal of radiology
Published: September 27, 2018
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
Journal: European radiology
Published: June 11, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Journal: Journal of viral hepatitis
Published: April 09, 2018
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: January 10, 2018
Last Updated: 09/26/2026